Industry

Developed a unique current waveform that enhances the saltiness of low-sodium foods by approximately 1.5 times. Spoon and bowl-shaped “Electric Salt” devices with this current waveform have been developed. Joint demonstration experiment with two companies proposing healthy eating started in September. Aiming to launch the device in Japan in 2023.   TOKYO–(BUSINESS WIRE)–Kirin Holdings Company, … [Read more…]

ROSENBERG, Texas–(BUSINESS WIRE)–Seatex, LLC (“Seatex”, or the “Company”), a leading specialty chemical manufacturer and formulator, is pleased to announce the acquisition of ChemQuest Chemicals, LLC (“ChemQuest”), a custom chemical manufacturer headquartered in Pasadena, Texas. For over twenty-five years, ChemQuest has provided custom toll manufacturing services to customers globally, with expertise in complex blending and reactionary … [Read more…]

— Approval Marks Kite’s Fourth Indication in Europe for its Two Cell Therapies and First in Leukemia — — Overall Complete Remission of 71% and a Median Overall Survival of More Than Two Years for All Patients and Almost Four Years for Responders Demonstrated in ZUMA-3 Trial– SANTA MONICA, Calif.–(BUSINESS WIRE)–Kite, a Gilead Company (Nasdaq: … [Read more…]

The seasoned executive will support and further the biotech company’s cell therapeutics growth by facilitating company expansion, capitalization and strategic development. DENVER–(BUSINESS WIRE)–$GLTI #biotech–James Johnston, an innovative executive with extensive financial and strategic experience with global organizations, has joined the board of directors of Greyledge Technologies, Inc. (“Greyledge” or “the Company”). He has served as … [Read more…]

PLANO, Texas–(BUSINESS WIRE)–Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company, today announced that management will participate in investor meetings at the Citi 17th Annual BioPharma Conference on September 7 – 8, 2022 in Boston, Massachusetts. About Reata Reata is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients … [Read more…]

LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Inc. (NYSE: HUM) will host a virtual Investor Update on Thursday, September 15, 2022. The Investor Update will include presentations by company leaders focusing on Humana’s strategic direction, operational and financial progress as well as expectations for future performance. Presentations will begin at 8:30 a.m. Eastern. The Investor Update webcast and virtual … [Read more…]

Chief Scientific Officer, Howard Bernstein, M.D., Ph.D., to Become Member of the Company’s Board of Directors, Effective October 31, 2022 CSO Responsibilities to be Shared Among Ipsita Roymoulik, Ph.D., Scott Loughhead, Ph.D., and Maisam Dadgar as Senior Leaders of Chemistry, Manufacturing and Controls; Translational Research; and Engineering WATERTOWN, Mass.–(BUSINESS WIRE)–SQZ Biotechnologies Company (NYSE: SQZ), focused … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will present an overview of the Company at the hybrid H.C. Wainwright 24th Annual Global Investment Conference, which will be held September 12-14, 2022. The virtual presentation will be available for … [Read more…]

EL SEGUNDO, Calif.–(BUSINESS WIRE)–The Beachbody Company, Inc. (NYSE: BODY) (“Beachbody” or the “Company”), a leading subscription health and wellness company, today announced that Beachbody’s Co-Founder, Chairman and Chief Executive Officer, Carl Daikeler, and Chief Financial Officer, Marc Suidan, will participate in a fireside chat at the Jefferies Virtual Fitness & Wellness Summit on Monday, September … [Read more…]

Expected to add $33 million in cash at closing to Equillium’s balance sheet and extend operating runway into 2024 Acquisition includes novel drug candidate MET642, an orally delivered Phase 2 ready FXR agonist for ulcerative colitis Preston Klassen, M.D., MHS, to be appointed to the Board of Directors LA JOLLA, Calif.–(BUSINESS WIRE)–$EQ #GVHD–Equillium, Inc. (Nasdaq: … [Read more…]